Johnson & Johnson vs Post Holdings: Founders, CEOs and History
Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato. Post Holdings was founded in 2012 by William P. Stiritz and is led by Nicolas Catoggio.
Company facts
Johnson & Johnson
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Current CEO
- Joaquin Duato
- Employees
- 140,800
Post Holdings
- Founded
- 2012
- Headquarters
- St. Louis, Missouri
- Current CEO
- Nicolas Catoggio
- Employees
- 13,180
Founders
Johnson & Johnson
Robert Wood Johnson
Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.
James Wood Johnson
James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.
Edward Mead Johnson
Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.
Post Holdings
William P. Stiritz
William P. Stiritz is the founding Chairman and CEO of the modern Post Holdings. When Ralcorp spun off its Post cereal business in February 2012, Stiritz took charge of the new company and began the acquisition strategy that later added Michael Foods and MOM B…
CEOs and their tenures
Johnson & Johnson
- Ralph Larsen1989–2002
Former Chairman and Chief Executive Officer
Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.
Source - William Weldon2002–2012
Former Chairman and Chief Executive Officer
Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.
Source - Alex Gorsky2012–2022
Former Chairman and Chief Executive Officer
Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.
Source - Joaquin Duato2022–present
Chairman and Chief Executive Officer
Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.
Source
Post Holdings
- William P. Stiritz2012–2014
Chairman and Chief Executive Officer
As the legendary Chairman and former CEO, the highly revered financial architect completely defined the company's complex, private-equity-style corporate structure.
Source - Robert V. Vitale2014–present
Executive Chairman (CEO 2014-2026)
Previously Post's CFO; from October 1, 2026 advises on capital allocation as Executive Chairman.
Source - Matthew J. Mainer2022–present
Chief Financial Officer and Treasurer
As CFO, he steers the company's aggressive, highly acquisitive capital allocation strategy, acting as the primary architect behind its massive M&A playbook.
Source - Nicolas Catoggio2026–present
President and Chief Executive Officer
Former Boston Consulting Group Managing Director and Senior Partner who advised Post on M&A diligence and integrations before joining.
Source
Timeline: Johnson & Johnson and Post Holdings side by side
1886Johnson & Johnson
Johnson & Johnson Founded
Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…
1920Johnson & Johnson
Band-Aid Brand Adhesive Bandages Introduced
J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.
1943Johnson & Johnson
Robert Wood Johnson II Writes 'Our Credo'
Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…
1944Johnson & Johnson
J&J Goes Public
Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.
1982Johnson & Johnson
Tylenol Cyanide Poisonings and Nationwide Recall
After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…
2012Johnson & Johnson
Alex Gorsky Becomes CEO
Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…
2012Post Holdings
Post Holdings Spin-Off
Post completed its separation from Ralcorp and began trading on the NYSE.
2014Post Holdings
Michael Foods Acquisition
Post expanded into egg products and foodservice through Michael Foods.
2015Post Holdings
MOM Brands Acquisition
Post broadened its cereal portfolio with MOM Brands.
2017Post Holdings
Weetabix Acquisition
Post added the U.K. Weetabix cereal business.
2018Post Holdings
Bob Evans Acquisition
Post expanded refrigerated retail and foodservice exposure.
2022Johnson & Johnson
Joaquin Duato Becomes CEO
Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.
2023Johnson & Johnson
Kenvue Separation
J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.
2025Johnson & Johnson
FY2025 Sales of $94.193B
Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.
2025Johnson & Johnson
Orthopaedics Separation Announced
In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.
2025Post Holdings
8th Avenue Acquired
Post acquired the remaining interest in 8th Avenue Food & Provisions.
2026Johnson & Johnson
Proposed Talc Resolution and Raised Guidance
J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.
2026Post Holdings
CEO Transition
Nicolas Catoggio became President and CEO on October 1, 2026.
Acquisitions
Johnson & Johnson
- Intra-Cellular Therapies2025$14.6B
- Shockwave Medical2024$13.1B
- Kenvue separation2023Undisclosed
- Abiomed2022$16.6B
- Actelion2017$30B
Post Holdings
- 8th Avenue Food & Provisions2025Undisclosed
- Pet Food Portfolio (J.M. Smucker)2023$1.2B
- Bob Evans Farms2018$1.5B
- Weetabix2017Undisclosed
- MOM Brands (Malt-O-Meal)2015$1.1B
- Michael Foods2014$2.5B
Questions about Johnson & Johnson vs Post Holdings
Who is the CEO of Johnson & Johnson and Post Holdings, Inc.?
Johnson & Johnson is led by Joaquin Duato and Post Holdings, Inc. is led by Nicolas Catoggio. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Johnson & Johnson founded vs Post Holdings, Inc.?
Johnson & Johnson was founded in 1886 — 126 years before Post Holdings, Inc., which was founded in 2012. Johnson & Johnson's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Post Holdings, Inc..
How many employees does Johnson & Johnson have compared to Post Holdings, Inc.?
Johnson & Johnson employs approximately 140,800 people, while Post Holdings, Inc. employs approximately 13,180. Johnson & Johnson has the larger workforce at 140,800 employees, compared to Post Holdings, Inc.'s 13,180. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Johnson & Johnson and Post Holdings, Inc. headquartered?
Both Johnson & Johnson and Post Holdings, Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Johnson & Johnson and Post Holdings, Inc.?
Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson. Post Holdings, Inc. was founded by William P. Stiritz.
Which company has a longer operating history — Johnson & Johnson or Post Holdings, Inc.?
Johnson & Johnson has been operating for approximately 140 years, making it the more established of the two companies. Post Holdings, Inc. has been in operation for around 14 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Johnson & Johnson vs Post Holdings overview